Similar articles

• Adjustment to aldosterone or desoxycorticosterone acetate induced sodium retention in patients with Addison's disease.

  AUGUST JT, NELSON DH. AUGUST JT, et al. J Clin Invest. 1959 Nov;38(11):1964-71. doi: 10.1172/JCI103975. J Clin Invest. 1959. PMID: 13795107 Free PMC article. No abstract available.
• DCA-like effects of butazolidine in normal subjects and in a patient with Addison's disease.

  GABRIEL JB, KATZ HM, REIMAN J, LUGER NM. GABRIEL JB, et al. Metabolism. 1955 Mar;4(2):119-28. Metabolism. 1955. PMID: 14355629 No abstract available.
• [Relation between 11-oxycorticosterone and 11-desoxycorticosterone in the urine of normal subjects, in Addison's disease and in chronic arthritic diseases].

  DI GIROLAMO L, NATOLI A, PATRONO V, PECORA P, ZILLI E. DI GIROLAMO L, et al. Policlinico Prat. 1951 Sep 17;58(38):1197-1200. Policlinico Prat. 1951. PMID: 14900060 Undetermined Language. No abstract available.
• [Influence of desoxycorticosterone and cortisone on kidney function in Addison's disease].

  BACZYK K, KUHN M, WOJTCZAK A, KOSOWICZ J. BACZYK K, et al. Pol Arch Med Wewn. 1958;28(1):1-12. Pol Arch Med Wewn. 1958. PMID: 13553949 Polish. No abstract available.
• [Various aspects of iron metabolism in Addison's disease].

  MEDURI D, NOTARIO A. MEDURI D, et al. Haematologica. 1957;42(5):503-11. Haematologica. 1957. PMID: 13448526 Italian. No abstract available.